RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-28
DOI
10.1186/s12935-019-1077-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies
- (2017) Mariam Gachechiladze et al. INTERNATIONAL JOURNAL OF CANCER
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
- (2017) Pingting Zhou et al. Molecular Cancer
- Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae
- (2017) Murugan Kalimutho et al. Molecular Oncology
- RAD51 interconnects between DNA replication, DNA repair and immunity
- (2017) Souparno Bhattacharya et al. NUCLEIC ACIDS RESEARCH
- Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients
- (2017) Yan Li et al. PLoS One
- Mitochondrial ROS control of cancer
- (2017) María del Pilar Sosa Idelchik et al. SEMINARS IN CANCER BIOLOGY
- Germline mutations in pancreatic cancer and potential new therapeutic options
- (2017) Rille Pihlak et al. Oncotarget
- Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
- (2017) Andrea E. Calvert et al. Cell Reports
- RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells
- (2017) Harry O. King et al. Stem Cell Reports
- Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
- (2017) Omar Elaskalani et al. World Journal of Gastrointestinal Oncology
- SIRT4 regulates cancer cell survival and growth after stress
- (2016) Seung Min Jeong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?
- (2016) Brian Budke et al. ChemMedChem
- FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
- (2016) S. Ji et al. CLINICAL CANCER RESEARCH
- ATM and ATR signaling at a glance
- (2016) Poorwa Awasthi et al. JOURNAL OF CELL SCIENCE
- Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer
- (2016) Shih-Hung Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- DNA Damage in Cancer Therapeutics: A Boon or a Curse?
- (2015) Anchit Khanna CANCER RESEARCH
- Pancreatic cancer: BRCA mutation and personalized treatment
- (2015) Guopei Luo et al. Expert Review of Anticancer Therapy
- Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer
- (2015) Robert C. Grant et al. GASTROENTEROLOGY
- Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition
- (2015) Ronan Russell et al. Nature Communications
- Familial pancreatic cancer: genetic advances
- (2014) A. K. Rustgi GENES & DEVELOPMENT
- Pancreatic cancer in the spotlight
- (2014) The Lancet Oncology LANCET ONCOLOGY
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
- (2013) E. B. Butler et al. CANCER RESEARCH
- The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
- (2013) Fabienne Guillaumond et al. CELL CYCLE
- Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
- (2012) T. W. H. Meijer et al. CLINICAL CANCER RESEARCH
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells
- (2009) R P Sahu et al. BRITISH JOURNAL OF CANCER
- Biology of HIF-1α
- (2008) A Weidemann et al. CELL DEATH AND DIFFERENTIATION
- Brick by brick: metabolism and tumor cell growth
- (2008) Ralph J DeBerardinis et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More